Patent Assignment
Reel/Frame 069793/0460
Change of Name
Recorded: 2024-12-27
Pages: 5
Assignor
OCUPHIRE PHARMA, INC.
Executed: 2024-10-22
Assignee
OPUS GENETICS, INC.
37000 GRAND RIVER AVE., SUITE 120, FARMINGTON HILLS, MICHIGAN, 48335
Covered Properties
(14)
Aqueous Ophthalmic Solutions of Phentolamine and Medical Uses Thereof
Aqueous Ophthalmic Solutions of Phentolamine and Medical Uses Thereof
Aqueous Ophthalmic Solutions of Phentolamine and Medical Uses Thereof
Aqueous Ophthalmic Solutions of Phentolamine and Medical Uses Thereof
Aqueous Ophthalmic Solutions of Phentolamine and Medical Uses Thereof
Methods and Compositions for Daily Ophthalmic Administration of Phentolamine to Improve Visual Performance
Methods and Compositions for Daily Ophthalmic Administration of Phentolamine to Improve Visual Performance
Methods and Compositions for Daily Ophthalmic Administration of Phentolamine to Improve Visual Performance
Methods and Compositions for Daily Ophthalmic Administration of Phentolamine to Improve Visual Performance
Methods and Compositions for Treatment of Presbyopia, Mydriasis, and Other Ocular Disorders
Methods and Compositions for Treatment of Presbyopia, Mydriasis, and Other Ocular Disorders
Methods and Compositions for Treatment of Presbyopia, Mydriasis, and Other Ocular Disorders
Highly Pure Phentolamine Mesylate and Methods for Making Same
Highly Pure Phentolamine Mesylate
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 17, 2015
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 035852/0850 →
Assignment of Assignor's Interest
Jun 17, 2015
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 035852/0843 →
Assignment of Assignor's Interest
Sep 5, 2017
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 043489/0357 →
Merger
Aug 21, 2018
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 046651/0294 →
Merger
Aug 21, 2018
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 046651/0152 →
Merger
Aug 21, 2018
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 046651/0179 →
Merger
Aug 21, 2018
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 046651/0264 →
Merger
Aug 21, 2018
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 046651/0342 →
Assignment of Assignor's Interest
Aug 27, 2018
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 046710/0939 →
Assignment of Assignor's Interest
Sep 6, 2018
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 046806/0305 →
Assignment of Assignor's Interest
Dec 13, 2019
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 051280/0752 →
Assignment of Assignor's Interest
Dec 13, 2019
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 051280/0773 →
Assignment of Assignor's Interest
Apr 7, 2020
From: PITLICK, WILLIAM H.; MEYER, ALAN R.; SOOCH, MINA; CHARIZANIS, KONSTANTINOS
To: OCUPHIRE PHARMA, INC.
Reel/Frame 052332/0950 →
Assignment of Assignor's Interest
Apr 7, 2020
From: PITLICK, WILLIAM H.; MEYER, ALAN R.; SOOCH, MINA; CHARIZANIS, KONSTANTINOS
To: OCUPHIRE PHARMA, INC.
Reel/Frame 052332/0988 →
Assignment of Assignor's Interest
Aug 16, 2021
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 057192/0272 →
Assignment of Assignor's Interest
Aug 16, 2021
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 057192/0603 →
Assignment of Assignor's Interest
Apr 1, 2022
From: PITLICK, WILLIAM H.; MEYER, ALAN R.; SOOCH, MINA; CHARIZANIS, KONSTANTINOS
To: OCUPHIRE PHARMA, INC.
Reel/Frame 059477/0530 →
Assignment of Assignor's Interest
Aug 9, 2022
From: ONICIU, DANIELA CARMEN
To: OCUPHIRE PHARMA, INC.
Reel/Frame 060756/0383 →
Assignment of Assignor's Interest
Mar 29, 2023
From: ONICIU, DANIELA CARMEN
To: OCUPHIRE PHARMA, INC.
Reel/Frame 063157/0013 →
Merger
Jun 14, 2023
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 063944/0922 →
Assignment of Assignor's Interest
Jun 14, 2023
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 063944/0943 →
Security Interest
Apr 21, 2026
From: OPUS GENETICS, INC.
To: OPCM SA LLC, AS PURCHASER AGENT FOR THE SECURED PARTIES
Reel/Frame 075478/0138 →